1. Home
  2. VRDN vs OBK Comparison

VRDN vs OBK Comparison

Compare VRDN & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • OBK
  • Stock Information
  • Founded
  • VRDN 2006
  • OBK 1912
  • Country
  • VRDN United States
  • OBK United States
  • Employees
  • VRDN N/A
  • OBK N/A
  • Industry
  • VRDN Medical Specialities
  • OBK Major Banks
  • Sector
  • VRDN Health Care
  • OBK Finance
  • Exchange
  • VRDN Nasdaq
  • OBK Nasdaq
  • Market Cap
  • VRDN 1.3B
  • OBK 1.1B
  • IPO Year
  • VRDN N/A
  • OBK 2018
  • Fundamental
  • Price
  • VRDN $17.28
  • OBK $37.51
  • Analyst Decision
  • VRDN Strong Buy
  • OBK Buy
  • Analyst Count
  • VRDN 11
  • OBK 5
  • Target Price
  • VRDN $38.50
  • OBK $42.20
  • AVG Volume (30 Days)
  • VRDN 667.1K
  • OBK 138.9K
  • Earning Date
  • VRDN 08-07-2025
  • OBK 07-23-2025
  • Dividend Yield
  • VRDN N/A
  • OBK 1.60%
  • EPS Growth
  • VRDN N/A
  • OBK N/A
  • EPS
  • VRDN N/A
  • OBK 2.23
  • Revenue
  • VRDN $302,000.00
  • OBK $340,866,000.00
  • Revenue This Year
  • VRDN N/A
  • OBK $13.29
  • Revenue Next Year
  • VRDN $17,102.33
  • OBK $5.86
  • P/E Ratio
  • VRDN N/A
  • OBK $16.83
  • Revenue Growth
  • VRDN 4.86
  • OBK N/A
  • 52 Week Low
  • VRDN $9.90
  • OBK $28.80
  • 52 Week High
  • VRDN $27.20
  • OBK $41.17
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 60.64
  • OBK 57.06
  • Support Level
  • VRDN $16.46
  • OBK $35.40
  • Resistance Level
  • VRDN $18.44
  • OBK $38.76
  • Average True Range (ATR)
  • VRDN 0.81
  • OBK 1.10
  • MACD
  • VRDN 0.04
  • OBK -0.13
  • Stochastic Oscillator
  • VRDN 57.82
  • OBK 62.80

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

Share on Social Networks: